Cargando…
Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition
The relatively rapid inhibition of microplasmin by α(2)-AP leads to short functional half-life of the molecule in vivo, causing inefficient clot dissolution, even after site-specific, local catheter-based delivery. Here, we describe a PEGylation approach for improving the therapeutic potential via i...
Autores principales: | Kaur, Navneet, Sinha, Prakash Kumar, Sahni, Girish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541275/ https://www.ncbi.nlm.nih.gov/pubmed/31141522 http://dx.doi.org/10.1371/journal.pone.0217234 |
Ejemplares similares
-
Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes
por: Hassan, Md. Mehedi, et al.
Publicado: (2020) -
Purification and characterization of mutant miniPlasmin for thrombolytic therapy
por: Lin, Xiaotao, et al.
Publicado: (2013) -
Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus
por: Kaur, Navneet, et al.
Publicado: (2020) -
Development of Site-Specific PEGylated Granulocyte Colony Stimulating Factor With Prolonged Biological Activity
por: Kumari, Monika, et al.
Publicado: (2020) -
Plasmin, Immunity, and Surgical Site Infection
por: Hastings, Stuart, et al.
Publicado: (2021)